Non-pharmacological interventions for the prevention of type 2 diabetes mellitus in low and middle-income countries: protocol for a systematic review and meta-analysis of randomized controlled trials
Abstract:Introduction
The disease burden caused by type 2 diabetes mellitus is a prime public health concern. The prevalence and rate of deaths from diabetes mellitus in low- and middle-income countries (LMICs) are higher than the high-income countries. Increased physical activity and a balanced diet are essential and successful measures to prevent the onset of diabetes mellitus. This systematic review aims to explore the available non-pharmacological approaches for the prevention of type 2 diabetes mel… Show more
“…The systematic review is registered in the International Prospective Register of Systematic Reviews. The protocol outlines the approach in depth, including the development of the search strategy, double-screening, double-data extraction, double-quality assessment of included articles and narrative synthesis 27. A detailed search strategy (online supplemental table 1) was constructed using the keywords including Exercise, ‘Physical activity’, ‘Nutritional therapy’’, ‘Meal plan’, ‘Weight loss’, ‘Lifestyle change’, ‘Lifestyle modification’, Diabetes, ‘Diabetes mellitus’, ‘Type 2 diabetes mellitus’’, T2DM, DM, LMICs, ‘Developing country’, ‘Peri-urban’’, urban, rural to search different electronic bibliographic database including MEDLINE through PubMed, Embase, the Cochrane Library (Cochrane Central Register of Controlled Trials-CENTRAL), Web of Science, ClinicalTrials.gov, International Clinical Trials Registry Platform, etc.…”
ObjectiveDiabetes poses serious health threats and economic burdens to patients, especially in low-income and middle-income countries (LMICs). This systematic review searches for non-pharmacological interventions for the prevention of type-2 diabetes mellitus (T2DM) among patients who are non-diabetic and pre-diabetic from LMICs.SettingsLMICs.ParticipantsAdult population aged over 18 years without having diabetes.Primary and secondary outcomesPrimary outcome is to measure the change in the incidence of T2DM. The secondary outcome is to measure changes in glycated haemoglobin (HbA1c) level, weight/body mass index (BMI), fasting glucose level and 2-hour glucose from baseline of the included randomised controlled trials.MethodsThis review has been conducted following the standard systematic review guidelines. A total of six electronic databases including MEDLINE, Embase, the Cochrane Library, Web of Science, ClinicalTrials.gov and International Clinical Trials Registry Platform were searched in February 2021 using a comprehensive search strategy.Two sets of independent reviewers performed screening, risk of bias (ROB) assessment using the Cochrane ROB tool and data extraction. Narrative coalescence of selected articles was demonstrated using tables. No meta-analysis was performed due to the lack of homogenous intervention strategies and study settings.ResultA total of five studies were included for the review with a combined population of 1734 from three countries. Three of the studies showed a significant reduction in T2DM incidence after the intervention of physical training and dietary modifications. Four of the studies also demonstrated a significant reduction of different secondary outcomes like weight, BMI, fasting and 2-hour plasma glucose and HbA1c. All the studies demonstrated a low ROB in most of the bias assessment domains with some unclear results in allocation concealments.ConclusionsEmphasising non-pharmacological interventions for T2DM prevention can improve health outcomes and lessen the economic burdens, which will be of paramount importance in LMICs.Systematic review registration numberCRD42020191507
“…The systematic review is registered in the International Prospective Register of Systematic Reviews. The protocol outlines the approach in depth, including the development of the search strategy, double-screening, double-data extraction, double-quality assessment of included articles and narrative synthesis 27. A detailed search strategy (online supplemental table 1) was constructed using the keywords including Exercise, ‘Physical activity’, ‘Nutritional therapy’’, ‘Meal plan’, ‘Weight loss’, ‘Lifestyle change’, ‘Lifestyle modification’, Diabetes, ‘Diabetes mellitus’, ‘Type 2 diabetes mellitus’’, T2DM, DM, LMICs, ‘Developing country’, ‘Peri-urban’’, urban, rural to search different electronic bibliographic database including MEDLINE through PubMed, Embase, the Cochrane Library (Cochrane Central Register of Controlled Trials-CENTRAL), Web of Science, ClinicalTrials.gov, International Clinical Trials Registry Platform, etc.…”
ObjectiveDiabetes poses serious health threats and economic burdens to patients, especially in low-income and middle-income countries (LMICs). This systematic review searches for non-pharmacological interventions for the prevention of type-2 diabetes mellitus (T2DM) among patients who are non-diabetic and pre-diabetic from LMICs.SettingsLMICs.ParticipantsAdult population aged over 18 years without having diabetes.Primary and secondary outcomesPrimary outcome is to measure the change in the incidence of T2DM. The secondary outcome is to measure changes in glycated haemoglobin (HbA1c) level, weight/body mass index (BMI), fasting glucose level and 2-hour glucose from baseline of the included randomised controlled trials.MethodsThis review has been conducted following the standard systematic review guidelines. A total of six electronic databases including MEDLINE, Embase, the Cochrane Library, Web of Science, ClinicalTrials.gov and International Clinical Trials Registry Platform were searched in February 2021 using a comprehensive search strategy.Two sets of independent reviewers performed screening, risk of bias (ROB) assessment using the Cochrane ROB tool and data extraction. Narrative coalescence of selected articles was demonstrated using tables. No meta-analysis was performed due to the lack of homogenous intervention strategies and study settings.ResultA total of five studies were included for the review with a combined population of 1734 from three countries. Three of the studies showed a significant reduction in T2DM incidence after the intervention of physical training and dietary modifications. Four of the studies also demonstrated a significant reduction of different secondary outcomes like weight, BMI, fasting and 2-hour plasma glucose and HbA1c. All the studies demonstrated a low ROB in most of the bias assessment domains with some unclear results in allocation concealments.ConclusionsEmphasising non-pharmacological interventions for T2DM prevention can improve health outcomes and lessen the economic burdens, which will be of paramount importance in LMICs.Systematic review registration numberCRD42020191507
“…Each kilogram of weight loss results in a 16% relative risk reduction and strongly correlates with a decreased progression to Type 2 diabetes. 14 According to a clinical investigation carried out in Da Qing, China, diet or exercise or a combination of diet and exercise was significantly linked to reductions in the probability of acquiring diabetes by 31%, 46%, and 42%, respectively. 15 People with a higher likelihood of developing diabetes should undergo more frequent screenings.…”
Background and AimsDiabetes is recognized as a significant factor in both mortality and morbidity worldwide, affecting various demographics regardless of geographic location, age group, or gender. This correspondence aims to express concern and draw the attention of leaders and policymakers worldwide to this critical public health issue.MethodsA thorough literature search was conducted utilizing various databases, including Google Scholar, PubMed, Science Direct, and the International Diabetes Federation (IDF) website, to collect the required data. Keywords were strategically applied to enhance search results, with preference given to English‐language articles containing pertinent information.ResultsAccording to the 2021 report by the IDF, approximately 537 million individuals globally were affected with diabetes, constituting roughly 10.5% of the world's populace. This condition incurred healthcare expenditures totaling $966 billion. Projections indicate a surge in diabetes cases to 783 million by 2045, with associated healthcare costs estimated to surpass $1054 billion. However, almost half of all people with diabetes are unaware of their medical condition, with the highest prevalence of undiagnosed diabetes Mellitus (DM) found in low and middle‐income countries (LMICs) of the regions of Africa, the Western Pacific, and Southeast Asia.ConclusionCollaborating with the World Health Organization (WHO), LMIC governments should improve healthcare accessibility, including more frequent diabetes screenings for individuals aged ≥ 45 years and younger individuals at elevated risk of having a family history.
“…Consequently, it is possible that preventive measures may preclude T2D development. Accumulating evidence has demonstrated that early impaired insulin sensitivity and prediabetes can be addressed by nonpharmacological measures [62,71,72]. The latter may include reducing carbohydrate intake and increasing intake of healthy fats in combination with an anti-inflammatory diet (a dietary approach that emphasizes the consumption of foods with anti-inflammatory properties while minimizing or avoiding foods that can promote inflammation) to reduce systemic inflammation [73].…”
“…The latter may include reducing carbohydrate intake and increasing intake of healthy fats in combination with an anti-inflammatory diet (a dietary approach that emphasizes the consumption of foods with anti-inflammatory properties while minimizing or avoiding foods that can promote inflammation) to reduce systemic inflammation [73]. Furthermore, enhanced physical activity and exercise, especially exercises which build skeletal muscle (i.e., weight lifting, burst training, or high-intensity interval training), as well as effective management of psychological stress, can improve insulin sensitivity [62,71,72]. Given that antipsychotic agents are essential in treating schizophrenia, and that the risk of prediabetes and T2D rapidly increases following the initiation of antipsychotic treatment, nonpharmacological measures may be clinically beneficial.…”
Schizophrenia is a complex psychotic disorder with co-occurring conditions, including insulin resistance and type 2 diabetes (T2D). It is well established that T2D and its precursors (i.e., insulin resistance) are more prevalent in patients with schizophrenia who are treated with antipsychotics, as well as in antipsychotic-naïve patients experiencing their first episode of psychosis, compared with the general population. However, the mechanism(s) underlying the increased susceptibility, shared genetics, and possible cause-effect relationship between schizophrenia and T2D remain largely unknown. The objective of this narrative review was to synthesize important studies, including Mendelian randomization (MR) analyses that have integrated genome-wide association studies (GWAS), as well as results from in vitro models, in vivo models, and observational studies of patients with schizophrenia. Both GWAS and MR studies have found that schizophrenia and T2D/insulin resistance share genetic risk factors, and this may mediate a connection between peripheral or brain insulin resistance and T2D with cognition impairment and an increased risk of developing prediabetes and T2D in schizophrenia. Moreover, accumulating evidence supports a causal role for insulin resistance in schizophrenia and emphasizes the importance of a genetic basis for susceptibility to T2D in patients with schizophrenia before they receive psychotic treatment. The present findings and observations may have clinical implications for the development of better strategies to treat patients with schizophrenia, with both pharmacological (i.e., samidorphan, empagliflozin) and/or nonpharmacological (i.e., lifestyle changes) approaches. Additionally, this review may benefit the design of future studies by physicians and clinical investigators.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.